$ZCMD
Zhongchao Inc. Stock $zcmd

$zcmd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023038650 Filed on May 12, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$6.856M	$14.15M	$7.681M
YoY Change	-10.74%	-13.16%	-19.38%
Cost Of Revenue	$5.558M	$7.795M	$3.710M
YoY Change	49.8%	13.66%	13.23%
Gross Profit	$1.298M	$6.357M	$3.971M
YoY Change	-67.31%	-32.65%	-36.47%
Gross Profit Margin	18.93%	44.92%	51.7%
Selling, General & Admin	$4.537M	$8.900M	$4.808M
YoY Change	-5.64%	-1.12%	48.89%
% of Gross Profit	349.54%	140.0%	121.09%
Research & Development	$258.2K	$411.5K	$342.8K
YoY Change	-24.67%	-45.77%	-16.88%
% of Gross Profit	19.9%	6.47%	8.63%
Depreciation & Amortization	$254.9K	$241.8K	$198.6K
YoY Change	28.38%	-29.21%	-1.85%
% of Gross Profit	19.64%	3.8%	5.0%
Operating Expenses	$4.795M	$9.311M	$5.151M
YoY Change	-6.91%	-4.59%	41.44%
Operating Profit	-$3.497M	-$2.954M	-$1.180M
YoY Change	196.35%	821.14%	-145.23%
Interest Expense	$59.10K	$142.0K	$110.2K
YoY Change	-46.37%	-19.31%	60.6%
% of Operating Profit
Other Income/Expense, Net	$509.8K	$262.4K	-$85.04K
YoY Change	-699.45%	671.89%	-128.19%
Pretax Income	-$2.928M	-$2.550M	-$1.155M
YoY Change	153.55%	2202.49%	-138.76%
Income Tax	-$12.38K	$272.3K	-$392.0K
% Of Pretax Income
Net Earnings	-$3.034M	-$2.822M	-$762.9K
YoY Change	297.76%	-1282.52%	-125.12%
Net Earnings / Revenue	-44.26%	-19.94%	-9.93%
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	-$0.12	-$0.11	-$30.58K
COMMON SHARES
Basic Shares Outstanding		26.00M shares
Diluted Shares Outstanding		26.00M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.04M	$12.04M	$14.21M
YoY Change	-15.29%	-15.29%	-16.92%
Cash & Equivalents	$11.52M	$11.52M	$13.91M
Short-Term Investments	$518.4K	$518.4K	$296.2K
Other Short-Term Assets	$493.0K	$1.343M	$770.7K
YoY Change	-36.03%	74.21%	-64.45%
Inventory	$189.1K	$189.1K
Prepaid Expenses	$1.028M		$395.0K
Receivables	$6.773M	$6.773M	$9.219M
Other Receivables	$2.066M	$2.361M	$3.053M
Total Short-Term Assets	$22.70M	$22.70M	$27.25M
YoY Change	-16.69%	-16.69%	-7.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.891M	$5.558M	$4.129M
YoY Change	-5.76%	34.61%	100.15%
Goodwill	$5.768M
YoY Change
Intangibles	$912.1K		$30.26K
YoY Change	2914.16%
Long-Term Investments	$1.264M	$1.264M	$2.143M
YoY Change	-41.03%	-41.03%	70.27%
Other Assets	$2.104M	$2.104M	$2.358M
YoY Change	-10.76%	-10.76%	57.57%
Total Long-Term Assets	$15.91M	$15.91M	$9.014M
YoY Change	76.51%	76.51%	72.65%
TOTAL ASSETS
Total Short-Term Assets	$22.70M	$22.70M	$27.25M
Total Long-Term Assets	$15.91M	$15.91M	$9.014M
Total Assets	$38.61M	$38.61M	$36.27M
YoY Change	6.47%	6.47%	4.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$140.8K	$140.8K	$38.93K
YoY Change	261.76%	261.75%	-90.47%
Accrued Expenses	$1.336M	$1.157M	$1.064M
YoY Change	25.61%	8.78%	1.93%
Deferred Revenue	$395.3K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.165M	$4.165M	$3.588M
YoY Change	16.07%	16.07%	20.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.222M	$1.222M	$112.6K
YoY Change	985.22%	985.22%
Total Long-Term Liabilities	$1.222M	$1.222M	$112.6K
YoY Change	985.22%	985.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.165M	$4.165M	$3.588M
Total Long-Term Liabilities	$1.222M	$1.222M	$112.6K
Total Liabilities	$5.595M	$8.686M	$3.701M
YoY Change	51.18%	134.7%	24.11%
SHAREHOLDERS EQUITY
Retained Earnings	$4.124M		$7.181M
YoY Change	-42.57%
Common Stock	$2.054K		$1.946K
YoY Change	5.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.93M	$29.93M	$32.57M
YoY Change
Total Liabilities & Shareholders Equity	$38.61M	$38.61M	$36.27M
YoY Change	6.47%	6.47%	4.17%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$3.034M	-$2.822M	-$762.9K
YoY Change	297.76%	-1282.52%	-125.12%
Depreciation, Depletion And Amortization	$254.9K	$241.8K	$198.6K
YoY Change	28.38%	-29.21%	-1.85%
Cash From Operating Activities	$134.9K	-$661.7K	$1.248M
YoY Change	-89.19%	-123.12%	-6.5%
INVESTING ACTIVITIES
Capital Expenditures	$1.575M	$1.616M	$74.64K
YoY Change	2010.37%	-189.78%	-469.32%
Acquisitions		$160.9K
YoY Change
Other Investing Activities	$1.390M	-$1.731M	$11.33K
YoY Change	12164.08%	-21.95%	-100.29%
Cash From Investing Activities	-$185.7K	-$3.347M	$85.96K
YoY Change	-316.0%	-16.69%	-102.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	270.0	$1.851M	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	134.9K	-$661.7K	1.248M
Cash From Investing Activities	-185.7K	-$3.347M	85.96K
Cash From Financing Activities	270.0	$1.851M	0.000
Net Change In Cash	-50.52K	-$2.395M	1.334M
YoY Change	-103.79%	107.24%	-150.92%
FREE CASH FLOW
Cash From Operating Activities	$134.9K	-$661.7K	$1.248M
Capital Expenditures	$1.575M	$1.616M	$74.64K
Free Cash Flow	-$1.440M	-$2.278M	$1.173M
YoY Change	-222.77%	-148.86%	-13.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39229
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Nanxi Creative Center
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 218
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	841 Yan’an Middle Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Jing’An District
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	200040
CY2022	dei	Security12b Title Security12bTitle	Class A Ordinary shares, par value $0.0001
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11520453	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13914982	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	518416	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	296158	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6772988	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9218883	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	189106	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1027989	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	394971	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	115989	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1840000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2660668	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	226179	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	392305	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493040	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	375709	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	22704160	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	27253676	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1179300	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	1993285	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	84606	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	150000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5767504	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3890947	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3923086	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	239481	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	181233	usd
CY2022Q4	zcmd	Prepayments For Lease Of Land PrepaymentsForLeaseOfLand	304787	usd
CY2021Q4	zcmd	Prepayments For Lease Of Land PrepaymentsForLeaseOfLand	353347	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	912054	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30259	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1666777	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	205824	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1864729	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2176710	usd
CY2022Q4	us-gaap	Assets Assets	38614345	usd
CY2021Q4	us-gaap	Assets Assets	36267420	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	140834	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	38933	usd
CY2022Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	395263	usd
CY2021Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	7432	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2292765	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2478273	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	480633	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	88968	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	855540	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	974801	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4165035	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3588407	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1221845	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112591	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	208200	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5595080	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3700998	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2054	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1946	usd
CY2022Q4	zcmd	Common Stock Value1 CommonStockValue1	550	usd
CY2021Q4	zcmd	Common Stock Value1 CommonStockValue1	550	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24998388	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22986975	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1315017	usd
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1199054	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4124037	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7180891	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-511824	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1197006	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29928222	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32566422	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	3091043	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33019265	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32566422	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38614345	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36267420	usd
CY2022	us-gaap	Revenues Revenues	14151516	usd
CY2021	us-gaap	Revenues Revenues	16296770	usd
CY2020	us-gaap	Revenues Revenues	17989788	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	7794852	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	6857944	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	6117640	usd
CY2022	us-gaap	Gross Profit GrossProfit	6356664	usd
CY2021	us-gaap	Gross Profit GrossProfit	9438826	usd
CY2020	us-gaap	Gross Profit GrossProfit	11872148	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2099968	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3137316	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3441941	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6799634	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5863373	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3124301	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	411524	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	758878	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	816553	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9311126	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9759567	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	7382795	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2954462	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-320741	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	4489353	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	142014	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	175987	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	146965	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	262442	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34001	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	305566	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2550006	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110753	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4941884	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	272313	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-349418	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484787	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2020	us-gaap	Profit Loss ProfitLoss	4457097	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	118572	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1283	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2940891	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	238665	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4458380	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1715262	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-281793	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1259984	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4537581	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	520458	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	5717081	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	112139	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1283	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4649722	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	520458	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5718364	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25997757	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24938513	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24425637	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.113
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.183
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15338527	usd
CY2020	zcmd	Reversal Of Sharebased Compensation Expenses ReversalOfSharebasedCompensationExpenses	168350	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10610183	usd
CY2020	us-gaap	Profit Loss ProfitLoss	4457097	usd
CY2020	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	1259984	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31834141	usd
CY2021	zcmd	Reversal Of Sharebased Compensation Expenses ReversalOfSharebasedCompensationExpenses	211823	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	281793	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32566422	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1850744	usd
CY2022	zcmd	Reversal Of Sharebased Compensation Expenses ReversalOfSharebasedCompensationExpenses	160777	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2978903	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-1715262	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33019265	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2020	us-gaap	Profit Loss ProfitLoss	4457097	usd
CY2022	zcmd	Writing Off Against Accounts Receivable WritingOffAgainstAccountsReceivable	753447	usd
CY2021	zcmd	Writing Off Against Accounts Receivable WritingOffAgainstAccountsReceivable	1449827	usd
CY2020	zcmd	Writing Off Against Accounts Receivable WritingOffAgainstAccountsReceivable	336367	usd
CY2022	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	383286	usd
CY2021	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	341608	usd
CY2020	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	202325	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	96921	usd
CY2022	zcmd	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	347025	usd
CY2021	zcmd	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	361369	usd
CY2020	zcmd	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	222353	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	160777	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	211823	usd
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	168350	usd
CY2022	zcmd	Deferred Tax Expenses Benefits DeferredTaxExpensesBenefits	134125	usd
CY2021	zcmd	Deferred Tax Expenses Benefits DeferredTaxExpensesBenefits	-1346616	usd
CY2020	zcmd	Deferred Tax Expenses Benefits DeferredTaxExpensesBenefits	-58424	usd
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-240489	usd
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-58403	usd
CY2020	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-10331	usd
CY2022	zcmd	Downward Adjustment In Investments In An Equity Security DownwardAdjustmentInInvestmentsInAnEquitySecurity	65394	usd
CY2022	zcmd	Equity Investment Loss EquityInvestmentLoss	-80	usd
CY2021	zcmd	Equity Investment Loss EquityInvestmentLoss	-13758	usd
CY2020	zcmd	Equity Investment Loss EquityInvestmentLoss	-25622	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1076292	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104230	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5486914	usd
CY2022	zcmd	Prepayments Prepayments	-659496	usd
CY2021	zcmd	Prepayments Prepayments	171144	usd
CY2021	zcmd	Loans Repayment From Third Parties LoansRepaymentFromThirdParties	1075098	usd
CY2022	us-gaap	Increase Decrease In Lease Acquisition Costs IncreaseDecreaseInLeaseAcquisitionCosts	-6206	usd
CY2020	zcmd	Prepayments Prepayments	-197402	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	118888	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	193833	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-66148	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1302009	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1143200	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	103825	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-375144	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	260350	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	369249	usd
CY2021	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	496	usd
CY2020	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	6398	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3557	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	905733	usd
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	535981	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-167585	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-4430	usd
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	179738	usd
CY2022	zcmd	Lease Liability LeaseLiability	-306392	usd
CY2021	zcmd	Lease Liability LeaseLiability	-362567	usd
CY2020	zcmd	Lease Liability LeaseLiability	-230819	usd
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	325992	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-661740	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2861848	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1037839	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1615905	usd
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1799860	usd
CY2020	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	160602	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1112440	usd
CY2022	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	245467	usd
CY2020	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	688267	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	996638	usd
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2043259	usd
CY2022	zcmd	Release From Shortterm Investments ReleaseFromShorttermInvestments	533891	usd
CY2021	zcmd	Release From Shortterm Investments ReleaseFromShorttermInvestments	1678367	usd
CY2020	zcmd	Investment In A Limited Partnership InvestmentInALimitedPartnership	1217039	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	708129	usd
CY2021	zcmd	Investment In An Equity Security InvestmentInAnEquitySecurity	-150000	usd
CY2022	zcmd	Acquisition Of A Subsidiary AcquisitionOfASubsidiary	3055432	usd
CY2022	zcmd	Loan Repayment Fromprovided To A Related Party LoanRepaymentFromprovidedToARelatedParty	139694	usd
CY2021	zcmd	Loan Repayment Fromprovided To A Related Party LoanRepaymentFromprovidedToARelatedParty	-387549	usd
CY2020	zcmd	Loan Repayment Fromprovided To A Related Party LoanRepaymentFromprovidedToARelatedParty	14489	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1032219	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	3725211	usd
CY2022	zcmd	Loans Repayment From Third Parties LoansRepaymentFromThirdParties	1806772	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3346658	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4017284	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4094678	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11886363	usd
CY2020	zcmd	Payment Of Expenses Relating To Initial Public Offerings PaymentOfExpensesRelatingToInitialPublicOfferings	388709	usd
CY2022	zcmd	Proceeds From Issuance Of Ordinary Shares In Connection With Direct Offering ProceedsFromIssuanceOfOrdinarySharesInConnectionWithDirectOffering	1850744	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1850744	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11497654	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-236875	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2529	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	875258	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2394529	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1157965	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7240395	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13914982	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15072947	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7832552	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11520453	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13914982	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15072947	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	134232	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	91464	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2642	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1774723	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	555639	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37919	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	210868	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	160940	usd
CY2019Q3	us-gaap	Shares Issued SharesIssued	1350068	shares
CY2019Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	675000	shares
CY2022	zcmd	Percentage Of Economic Beneficial Interest PercentageOfEconomicBeneficialInterest	0.0519	pure
CY2022	zcmd	Ownership Voting Percentage OwnershipVotingPercentage	0.0131	pure
CY2019Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	20000000	cny
CY2019Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	2900000	usd
CY2019Q3	zcmd	Initial Equity Interest Pledge Agreement InitialEquityInterestPledgeAgreement	P20Y
CY2019Q3	zcmd	Service Fees ServiceFees	1	pure
CY2022	zcmd	Minority Equity Interest MinorityEquityInterest	0.40	pure
CY2022	zcmd	Foreign Currency Exchange Rate Translations Balance Sheet Excep Equity ForeignCurrencyExchangeRateTranslationsBalanceSheetExcepEquity	6.8972
CY2021	zcmd	Foreign Currency Exchange Rate Translations Balance Sheet Excep Equity ForeignCurrencyExchangeRateTranslationsBalanceSheetExcepEquity	6.3726
CY2022	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	6.7290
CY2021	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	6.4508
CY2020	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	6.9020
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates and assumptions using the currently available information. Changes in facts and circumstances may cause the Company to revise its estimates. The Company bases its estimates on past experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Estimates are used when accounting for items and matters including, but not limited to, fair value of the Company’s ordinary shares, fair value of the Company’s subsidiaries, determinations of the useful lives and valuation of long-lived assets, valuation of goodwill, estimates of allowances for doubtful accounts, valuation of deferred tax assets, and other provisions and contingencies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	zcmd	Wrote Off Against Accounts Receivables WroteOffAgainstAccountsReceivables	753447	usd
CY2021Q4	zcmd	Wrote Off Against Accounts Receivables WroteOffAgainstAccountsReceivables	1449827	usd
CY2020Q4	zcmd	Wrote Off Against Accounts Receivables WroteOffAgainstAccountsReceivables	336367	usd
CY2022Q4	zcmd	Written Off WrittenOff	543315	usd
CY2021Q4	zcmd	Written Off WrittenOff	1449827	usd
CY2020Q4	zcmd	Written Off WrittenOff	336367	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	207269	usd
CY2022	zcmd	Prepayment Prepayment	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Prepayments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepayments represent amounts advanced to suppliers for providing services to the Company. The suppliers usually require advance payments when the Company orders service and the prepayments will be utilized to offset the Company’s future payments. These amounts are unsecured, non-interest bearing and generally short-term in nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	zcmd	Government Grants GovernmentGrants	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Investments in an equity security</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity securities not accounted for using the equity method are carried at fair value with unrealized gains and losses recorded in the consolidated statements of operations and comprehensive (loss) income, according to ASC 321 “Investments — Equity Securities”, which the Company adopted beginning January 1, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, the Company had investment in one equity security. The Company elected to record an equity investment in privately held companies using the measurement alternative at cost, less impairment, with subsequent adjustments for observable price changes resulting from orderly transactions for identical or similar investments of the same issuer. As a practical expedient, the Company uses Net Asset Value (“NAV”) or its equivalent to measure the fair value of the investment in the fund. NAV is primarily determined based on information provided by financial institution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity investment in privately held companies accounted for using the measurement alternative are subject to periodic impairment reviews. The Company’s impairment analysis considers both qualitative and quantitative factors that may have a significant effect on the fair value of the equity security, including consideration of the impact of the COVID-19 pandemic.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2022	us-gaap	Regulatory Liability Amortization Period RegulatoryLiabilityAmortizationPeriod	P1Y
CY2022	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0.003	pure
CY2021	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0.012	pure
CY2020	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0	pure
CY2022	zcmd	Medical Training And Education Services MedicalTrainingAndEducationServices	6604487	usd
CY2021	zcmd	Medical Training And Education Services MedicalTrainingAndEducationServices	8754120	usd
CY2020	zcmd	Medical Training And Education Services MedicalTrainingAndEducationServices	10543852	usd
CY2022	zcmd	Assistance In Patientaid Projects AssistanceInPatientaidProjects	6288602	usd
CY2021	zcmd	Assistance In Patientaid Projects AssistanceInPatientaidProjects	7343343	usd
CY2020	zcmd	Assistance In Patientaid Projects AssistanceInPatientaidProjects	7445936	usd
CY2022	zcmd	Sales Of Patented Drug SalesOfPatentedDrug	1216096	usd
CY2022	zcmd	Other Consulting Services OtherConsultingServices	42331	usd
CY2021	zcmd	Other Consulting Services OtherConsultingServices	199307	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	14151516	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	16296770	usd
CY2020Q4	us-gaap	Other Assets OtherAssets	17989788	usd
CY2022	zcmd	Cost Of Revenues CostOfRevenues	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cost of revenues</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues was comprised of direct related costs incurred for preparation of online medical training courses and offline education seminars and patient-aid projects and cost of patented drugs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of preparation of online medical training courses and offline education seminars and patient management services in patient-aid projects includes expenses of travelling and accommodation, seminar site-rental, video production and backdrop production, professional service fees charged by experts who provide online and offline seminars, salary and welfare expenses incurred by the key members of the editorial, design and production team, and labor cost for patient-aid projects. The travelling and accommodation expenses, including but not limited to the air-ticket expenses and hotel accommodation expenses, represented the costs arising from lecturers’ attendance and participation of the offline seminars. Other media expenses were incurred by the Company’s medical department for videos production, live streaming of the offline seminars, and materials collection to create online courses. These travelling, accommodation and media expenses are well budgeted before any agreements entered into by the Company and the customers. Therefore, such expenses are well covered by the customers under those agreements. The Company is not reimbursed by the customers separately.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
CY2021Q4	zcmd	Variable Interest Entity Advances From Customers VariableInterestEntityAdvancesFromCustomers	7432	usd
CY2022	zcmd	Employee Benefits EmployeeBenefits	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Employee benefits</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The full-time employees of the Company are entitled to staff welfare benefits including medical care, housing fund, pension benefits, unemployment insurance and other welfare, which are government mandated defined contribution plans. The Company is required to accrue for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant PRC regulations, and make cash contributions to the state-sponsored plans out of the amounts accrued. Total expenses for the plans were $817,345, $804,730, and $310,637 for the years ended December 31, 2022, 2021 and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	817345	usd
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	804730	usd
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	310637	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	411524	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	758878	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	816553	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	989900	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2204233	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	2851648	usd
CY2022	zcmd	Value Added Tax ValueAddedTax	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Value added tax</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to value added tax (“VAT”) and related surcharges on the revenues earned for both sales of products and rendering of services in the PRC. The applicable rate of value added tax is 6% on services and 13% on sales of products. The related surcharges for revenues derived from provision medical courses are deducted from gross receipts to arrive at net revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	zcmd	Value Added Taxs ValueAddedTaxs	0.06	pure
CY2022	zcmd	Sale Of Products SaleOfProducts	0.13	pure
CY2022Q4	zcmd	Variable Interest Entity Income Tax Payable VariableInterestEntityIncomeTaxPayable	2292765	usd
CY2022	zcmd	Amount Of Tax Benefit AmountOfTaxBenefit	0.50	pure
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassification</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain items in the financial statements of comparative period have been reclassified to conform to the financial statements for the current period. The reclassification has no impact on the total assets and total liabilities as of December 31, 2022 or on the statements of operations for the year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p>
CY2022	zcmd	Recently Issued Accounting Pronouncements RecentlyIssuedAccountingPronouncements	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recently issued accounting pronouncements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments – Credit Losses</i> (Topic 326): <i>Measurement of Credit Losses on Financial Instruments</i>. This ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. This ASU requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU requires enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of the Company’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the financial statements. The effective date was for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, for public business entities that meet the definition of an SEC filer and eligible to be Smaller Reporting Companies, or SRC, as defined by the SEC and all non-public business entities. As an “emerging growth company,” or EGC, the Company has elected to take advantage of the extended transition period provided in the Securities Act Section 7(a)(2)(B) for complying with new or revised accounting standards applicable to private companies. The Company will adopt ASU 2016-13 and its related amendments effective January 1, 2023, and the Company does not expect material impact on adoption of this standard on its consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material impact on its the consolidated financial position, statements of operations and cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p>
CY2022	zcmd	Significant Risks And Uncertainties SignificantRisksAndUncertainties	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Significant risks and uncertainties</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Assets that potentially subject the Company to significant concentration of credit risk primarily consist of cash and cash equivalents. The maximum exposure of such assets to credit risk is their carrying amount as at the balance sheet dates. As of December 31, 2022, the Company held cash and cash equivalents of $11,520,453, among which were $4,700,379 was deposited in financial institutions located in Mainland China, and each bank account is insured by the government authority with the maximum limit of RMB 500,000 (equivalent to approximately $72,500). The Company also held cash of $4,709,310 deposited in the financial institutions in the United States, and each bank account is insured with the maximum limit of $250,000 by Federal Deposit Insurance Corporation (“FDIC”) insurance. In addition, the Company maintains certain bank accounts in Japan with cash balance of $1,538,404, which are not insured by FDIC insurance or other insurance. To limit exposure to credit risk relating to deposits, the Company primarily place cash and cash equivalent deposits with large financial institutions which management believes are of high credit quality and the Company also continually monitors their credit worthiness.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s operations are carried out in China. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environments in the PRC as well as by the general state of the PRC’s economy. In addition, the Company’s business may be influenced by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, rates and methods of taxation among other factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of the Company’s operating activities and the Company’s assets and liabilities are denominated in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the Peoples’ Bank of China (“PBOC”) or other authorized financial institutions at exchange rates quoted by PBOC. Approval of foreign currency payments by the PBOC or other regulatory institutions requires submitting a payment application form together with suppliers’ invoices and signed contracts. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters, extreme weather conditions, health epidemics and other catastrophic incidents, such as the COVID-19 outbreak and spread, management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
CY2022Q4	zcmd	Deposited In Financial Institutions DepositedInFinancialInstitutions	4700379	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	500000	cny
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	72500	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4709310	usd
CY2022	us-gaap	Insurance Recoveries InsuranceRecoveries	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1538404	usd
CY2022Q4	zcmd	Variable Interest Entity Cash And Cash Equivalents VariableInterestEntityCashAndCashEquivalents	4500379	usd
CY2021Q4	zcmd	Variable Interest Entity Cash And Cash Equivalents VariableInterestEntityCashAndCashEquivalents	7117728	usd
CY2022Q4	zcmd	Variable Interest Entity Accounts Receivable VariableInterestEntityAccountsReceivable	6772988	usd
CY2021Q4	zcmd	Variable Interest Entity Accounts Receivable VariableInterestEntityAccountsReceivable	9218883	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	189106	usd
CY2022Q4	zcmd	Variable Interest Entity Other Current Assets VariableInterestEntityOtherCurrentAssets	1840182	usd
CY2021Q4	zcmd	Variable Interest Entity Other Current Assets VariableInterestEntityOtherCurrentAssets	2029794	usd
CY2022Q4	zcmd	Variable Interest Entity Investment In A Limited Partnership VariableInterestEntityInvestmentInALimitedPartnership	1179300	usd
CY2021Q4	zcmd	Variable Interest Entity Investment In A Limited Partnership VariableInterestEntityInvestmentInALimitedPartnership	1993285	usd
CY2022Q4	zcmd	Variable Interest Entity Property And Equipment Net VariableInterestEntityPropertyAndEquipmentNet	3111717	usd
CY2021Q4	zcmd	Variable Interest Entity Property And Equipment Net VariableInterestEntityPropertyAndEquipmentNet	3168441	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill Noncurrent DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent	5767504	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1666777	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	205824	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1800493	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2025043	usd
CY2022Q4	zcmd	Variable Interest Entity Other Noncurrent Assets VariableInterestEntityOtherNoncurrentAssets	1456322	usd
CY2021Q4	zcmd	Variable Interest Entity Other Noncurrent Assets VariableInterestEntityOtherNoncurrentAssets	414105	usd
CY2022Q4	zcmd	Variable Interest Entity Total Assets VariableInterestEntityTotalAssets	28284768	usd
CY2021Q4	zcmd	Variable Interest Entity Total Assets VariableInterestEntityTotalAssets	26173103	usd
CY2022Q4	zcmd	Variable Interest Entity Advances From Customers VariableInterestEntityAdvancesFromCustomers	395263	usd
CY2021Q4	zcmd	Variable Interest Entity Income Tax Payable VariableInterestEntityIncomeTaxPayable	2478273	usd
CY2022Q4	zcmd	Variable Interest Entity Operating Lease Liabilities VariableInterestEntityOperatingLeaseLiabilities	1702478	usd
CY2021Q4	zcmd	Variable Interest Entity Operating Lease Liabilities VariableInterestEntityOperatingLeaseLiabilities	201559	usd
CY2022Q4	zcmd	Variable Interest Entity Due To Zhongchao Inc VariableInterestEntityDueToZhongchaoInc	762962	usd
CY2021Q4	zcmd	Variable Interest Entity Due To Zhongchao Inc VariableInterestEntityDueToZhongchaoInc	599347	usd
CY2022Q4	zcmd	Variable Interest Entity Other Current Liabilities VariableInterestEntityOtherCurrentLiabilities	992558	usd
CY2021Q4	zcmd	Variable Interest Entity Other Current Liabilities VariableInterestEntityOtherCurrentLiabilities	1011371	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	208200	usd
CY2022Q4	zcmd	Variable Interest Entity Total Liabilities VariableInterestEntityTotalLiabilities	6354226	usd
CY2021Q4	zcmd	Variable Interest Entity Total Liabilities VariableInterestEntityTotalLiabilities	4297982	usd
CY2022	zcmd	Variable Interest Entity Revenues VariableInterestEntityRevenues	14151516	usd
CY2021	zcmd	Variable Interest Entity Revenues VariableInterestEntityRevenues	16096769	usd
CY2020	zcmd	Variable Interest Entity Revenues VariableInterestEntityRevenues	17989788	usd
CY2022	zcmd	Variable Interest Entity Income From Operations VariableInterestEntityIncomeFromOperations	-1716154	usd
CY2021	zcmd	Variable Interest Entity Income From Operations VariableInterestEntityIncomeFromOperations	418235	usd
CY2020	zcmd	Variable Interest Entity Income From Operations VariableInterestEntityIncomeFromOperations	4525855	usd
CY2022	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	-1427296	usd
CY2021	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	838838	usd
CY2020	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	4484029	usd
CY2021Q4	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	708129	usd
CY2021Q4	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	4568000	cny
CY2022Q1	zcmd	Cash Consideration CashConsideration	25000000	cny
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate	0.0667	pure
CY2022Q3	zcmd	Cash Consideration CashConsideration	3100000	usd
CY2022Q3	zcmd	Cash Consideration CashConsideration	20600000	cny
CY2022Q3	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate	0.0667	pure
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	60092	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1000406	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5767504	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	234225	usd
CY2022Q4	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	2585087	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	120261	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4008767	usd
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	3055432	usd
CY2022	zcmd	Fair Value Of Previously Held Equity Interests FairValueOfPreviouslyHeldEquityInterests	708129	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	393816	usd
CY2022Q4	zcmd	Notes Payable Related Partie Current And Noncurrent NotesPayableRelatedPartieCurrentAndNoncurrent	148610	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	4008767	usd
CY2022	zcmd	Estimated Useful Life EstimatedUsefulLife	P3Y
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	850	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage	0.0667	pure
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	393816	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2713000	cny
CY2022	zcmd	Cash Consideration CashConsideration	148610	usd
CY2022	zcmd	Cash Consideration CashConsideration	1000000	cny
CY2022	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	240489	usd
CY2021	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	58403	usd
CY2020	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	10331	usd
CY2022Q4	zcmd	Due From Related Partie DueFromRelatedPartie	205726	usd
CY2022Q4	us-gaap	Rental Properties RentalProperties	128194	usd
CY2021Q4	us-gaap	Rental Properties RentalProperties	203896	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	88720	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	78950	usd
CY2022Q4	zcmd	Prepaid Consulting Service Fees PrepaidConsultingServiceFees	803	usd
CY2021Q4	zcmd	Prepaid Consulting Service Fees PrepaidConsultingServiceFees	45607	usd
CY2022Q4	zcmd	Others Others	69597	usd
CY2021Q4	zcmd	Others Others	47256	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493040	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	375709	usd
CY2022	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	1323308	usd
CY2022	us-gaap	Payments To Employees PaymentsToEmployees	1112440	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1840000	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2660668	usd
CY2021	zcmd	Business Acquisition Preacquisition Contingency Total Amounts BusinessAcquisitionPreacquisitionContingencyTotalAmounts	5000000	cny
CY2021	zcmd	Business Acquisition Preacquisition Contingency Total Amounts BusinessAcquisitionPreacquisitionContingencyTotalAmounts	775098	usd
CY2022Q4	us-gaap	Business Acquisition Preacquisition Contingency Amount Of Settlement BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement	150000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	379879	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	636239	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3890947	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3923086	usd
CY2022	us-gaap	Depreciation Depreciation	241842	usd
CY2021	us-gaap	Depreciation Depreciation	312898	usd
CY2020	us-gaap	Depreciation Depreciation	176111	usd
CY2021Q2	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1397317	usd
CY2022Q4	us-gaap	Deferred Gain On Sale Of Property DeferredGainOnSaleOfProperty	1323308	usd
CY2022Q4	zcmd	Prepayments For Lease Of Land Gross PrepaymentsForLeaseOfLandGross	401031	usd
CY2021Q4	zcmd	Prepayments For Lease Of Land Gross PrepaymentsForLeaseOfLandGross	434045	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	96244	usd
CY2021Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	80698	usd
CY2022Q4	zcmd	Prepayments For Lease Of Land Net PrepaymentsForLeaseOfLandNet	304787	usd
CY2021Q4	zcmd	Prepayments For Lease Of Land Net PrepaymentsForLeaseOfLandNet	353347	usd
CY2022	zcmd	Amortization Expenses For Lease Of Land AmortizationExpensesForLeaseOfLand	22226	usd
CY2021	zcmd	Amortization Expenses For Lease Of Land AmortizationExpensesForLeaseOfLand	23185	usd
CY2020	zcmd	Amortization Expenses For Lease Of Land AmortizationExpensesForLeaseOfLand	21670	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	140951	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26671	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	912054	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30259	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	119218	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5525	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4544	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	338636	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	338636	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	227492	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5105	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2185	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	912054	usd
CY2022Q4	zcmd	Operating Loss OperatingLoss	1179300	usd
CY2021Q4	zcmd	Operating Loss OperatingLoss	1276466	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	1179300	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	1993285	usd
CY2020Q4	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	1217039	usd
CY2020Q4	zcmd	Partnership Interest Percentage PartnershipInterestPercentage	0.28	pure
CY2022	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	80	usd
CY2021	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	13758	usd
CY2020	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	25622	usd
CY2021Q4	us-gaap	Investment Company Contributed Capital To Committed Capital Ratio InvestmentCompanyContributedCapitalToCommittedCapitalRatio	0.47	pure
CY2021Q4	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	708129	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	150000	usd
CY2021	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	0.006	pure
CY2022	zcmd	Downward Adjustments In Investments In An Equity Security DownwardAdjustmentsInInvestmentsInAnEquitySecurity	65394	usd
CY2022Q4	zcmd	Other Tax Payable1 OtherTaxPayable1	379712	usd
CY2021Q4	zcmd	Other Tax Payable1 OtherTaxPayable1	616356	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	296866	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	301260	usd
CY2022Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	83367	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	95595	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57185	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	855540	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	974801	usd
CY2021Q4	zcmd	Value Added Tax Payable ValueAddedTaxPayable	354794	usd
CY2020Q4	zcmd	Value Added Tax Payable ValueAddedTaxPayable	579516	usd
CY2021Q4	zcmd	Local Taxes Payable LocalTaxesPayable	24918	usd
CY2020Q4	zcmd	Local Taxes Payable LocalTaxesPayable	36840	usd
CY2021Q4	zcmd	Other Tax Payable OtherTaxPayable	379712	usd
CY2020Q4	zcmd	Other Tax Payable OtherTaxPayable	616356	usd
CY2021	zcmd	Applicable Tax Rate Description ApplicableTaxRateDescription	The applicable tax rate for the first HKD$2 million of assessable profits is 8.25% and assessable profits above HKD$2 million will continue to be subject to the rate of 16.5% for corporations in Hong Kong, effective from the year of assessment 2018/2019. Before that, the applicable tax rate was 16.5% for corporations in Hong Kong.
CY2022	zcmd	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercent	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.30	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.30	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.30	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.125	pure
CY2021Q1	zcmd	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1 EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1	0.25	pure
CY2022	zcmd	Enterprise Income Tax Description EnterpriseIncomeTaxDescription	SMEs are entitled to a reduced EIT rate of a reduced EIT rate of 20%, 87.5% reduction of taxable income for the first RMB1,000,000 taxable income and 75% reduction of taxable income between RMB 1,000,000 and RMB 3,000,000, and no reduction for the remaining taxable income for the year ended December 31, 2022; 87.5% reduction of taxable income for the first RMB1,000,000 taxable income and 50% reduction of taxable income between RMB 1,000,000 and RMB 3,000,000, and no reduction for the remaining taxable income for the year ended December 31, 2021; and 75% reduction of taxable income for the first RMB1,000,000 taxable income and 50% reduction of taxable income between RMB 1,000,000 and RMB 3,000,000, and no reduction for the remaining taxable income for the years ended before December 31, 2020.
CY2018Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	1.75	pure
CY2022Q4	zcmd	Pr Cand Non Prc Total PRCandNonPRCTotal	-2550006	usd
CY2020Q4	zcmd	Pr Cand Non Prc Total PRCandNonPRCTotal	-110753	usd
CY2019Q4	zcmd	Pr Cand Non Prc Total PRCandNonPRCTotal	4941884	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-138188	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-997198	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-543211	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-134125	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1346616	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	58424	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	272313	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-349418	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	484787	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	zcmd	Effect Of Different Income Tax Rates In Other Jurisdictionsin Dollars EffectOfDifferentIncomeTaxRatesInOtherJurisdictionsinDollars	-0.0211	pure
CY2021	zcmd	Effect Of Different Income Tax Rates In Other Jurisdictionsin Dollars EffectOfDifferentIncomeTaxRatesInOtherJurisdictionsinDollars	-0.3411	pure
CY2020	zcmd	Effect Of Different Income Tax Rates In Other Jurisdictionsin Dollars EffectOfDifferentIncomeTaxRatesInOtherJurisdictionsinDollars	0	pure
CY2022	zcmd	Effective Income Tax Rate Reconciliation Preferential Tax Benefits EffectiveIncomeTaxRateReconciliationPreferentialTaxBenefits	-0.1272	pure
CY2021	zcmd	Effective Income Tax Rate Reconciliation Preferential Tax Benefits EffectiveIncomeTaxRateReconciliationPreferentialTaxBenefits	-1.6736	pure
CY2020	zcmd	Effective Income Tax Rate Reconciliation Preferential Tax Benefits EffectiveIncomeTaxRateReconciliationPreferentialTaxBenefits	0.1396	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0122	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.5484	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0035	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-0.0306	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-1.0455	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.0147	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.3422	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-1.0753	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1391	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.1068	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	3.1549	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.0981	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	842295	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	911799	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	25790	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	33590	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1052209	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1079962	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	178764	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	156928	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	51817	usd
CY2022	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	50502	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	13733	usd
CY2022Q4	zcmd	Lease Liabilities LeaseLiabilities	71024	usd
CY2021Q4	zcmd	Lease Liabilities LeaseLiabilities	31615	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	81910	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	37184	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	339495	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1864729	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2176710	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	208200	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	208200	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7166560	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4435381	usd
CY2022	zcmd	Net Operating Loss Carryforwards Description NetOperatingLossCarryforwardsDescription	The Company also has net operating loss carryforwards from PRC of $5,653,804 which expire starting in 2025 through 2027.
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	339495	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit	0.105	pure
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2940891	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	238665	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4458380	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25997757	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24938513	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24425637	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.113
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.183
CY2022	zcmd	Beijing Ougaini BeijingOugaini	19696	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	118888	usd
CY2022	zcmd	Beijings Ougaini BeijingsOugaini	115989	usd
CY2022	zcmd	Yang Weiguangi YangWeiguangi	226178	usd
CY2021	zcmd	Beijing Yisuizhenii BeijingYisuizhenii	392305	usd
CY2022	zcmd	Total Total	226178	usd
CY2021	zcmd	Total Total	392305	usd
CY2022Q4	us-gaap	Policyholder Funds PolicyholderFunds	144986	usd
CY2022	zcmd	Number Of Shareholders NumberOfShareholders	4	pure
CY2022Q4	zcmd	Common Stock Share Authorized CommonStockShareAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	zcmd	Ordinary Sahres Description OrdinarySahresDescription	Holders of Class A Ordinary Shares and Class B Class A Ordinary Shares have the same rights except for voting and conversion rights. In respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote and each Class B Ordinary Share will be entitled to 15 votes.
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.0625	pure
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1350068	shares
CY2022	zcmd	Economic Beneficial Interest Rate EconomicBeneficialInterestRate	0.0519	pure
CY2022	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.0131	pure
CY2022Q4	zcmd	Aftertax Profits AftertaxProfits	0.10	pure
CY2022Q4	zcmd	Reserve Funds ReserveFunds	0.50	pure
CY2022Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	115963	usd
CY2021Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	397552	usd
CY2020Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	385689	usd
CY2022	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2021	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2020	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2022Q4	zcmd	Statutory Reserve Funds StatutoryReserveFunds	1315017	usd
CY2021Q4	zcmd	Statutory Reserve Funds StatutoryReserveFunds	1199054	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	13314132	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	13198169	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.10	pure
CY2020	zcmd	Cost Of Revenue Percentage CostOfRevenuePercentage	0.10	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	427076	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.54
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.64
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	18000	shares
CY2021	zcmd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grants Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantsDateFairValue	-1.77
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	427076	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.53
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	137880	shares
CY2022	zcmd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grants Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantsDateFairValue	-2.37
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	307196	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.52
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	119880	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	18000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	15000	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.64
CY2021Q3	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	29520	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	18000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	15000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.16
CY2022Q4	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	20880	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160777	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	211832	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	168350	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	363670	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	61607	usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	111997	usd
CY2020	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	93439	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	99170	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	99826	usd
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	74911	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	160777	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	211823	usd
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	168350	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	37183491	usd
CY2021Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	36267420	usd
CY2022	zcmd	Sales Of Patented Drugs SalesOfPatentedDrugs	1430854	usd
CY2022Q4	us-gaap	Assets Assets	38614345	usd
CY2021Q4	us-gaap	Assets Assets	36267420	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1666777	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	205824	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	480633	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	88968	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1221845	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112591	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1702478	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	201559	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M25D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M17D
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	498166	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	426152	usd
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	312675	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	409595	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	480636	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	350934	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	550915	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	324647	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	317927	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	317980	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	397475	usd
CY2022Q4	zcmd	Total Futureminimumleasepayment TotalFutureminimumleasepayment	1908944	usd
CY2022Q4	zcmd	Operating Lease Less Imputed Interest OperatingLeaseLessImputedInterest	206466	usd
CY2022Q4	zcmd	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1702478	usd
CY2022	zcmd	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	zcmd	Downward Adjustment In Investments In An Equity Security DownwardAdjustmentInInvestmentsInAnEquitySecurity		usd
CY2020	zcmd	Downward Adjustment In Investments In An Equity Security DownwardAdjustmentInInvestmentsInAnEquitySecurity		usd
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies		usd
CY2020	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies		usd
CY2022	dei	Entity Registrant Name EntityRegistrantName	Zhongchao Inc.
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2021Q4	us-gaap	Inventory Net InventoryNet		usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24425637	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24938513	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25997757	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.010
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.113
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.183
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2020	zcmd	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2020	zcmd	Stock Issue During Period Value Buy Out Of A Noncontrolling Interests StockIssueDuringPeriodValueBuyOutOfANoncontrollingInterests		usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2021	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2020	zcmd	Release From Shortterm Investments ReleaseFromShorttermInvestments		usd
CY2022	zcmd	Investment In A Limited Partnership InvestmentInALimitedPartnership		usd
CY2021	zcmd	Investment In A Limited Partnership InvestmentInALimitedPartnership		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	zcmd	Investment In An Equity Security InvestmentInAnEquitySecurity		usd
CY2020	zcmd	Investment In An Equity Security InvestmentInAnEquitySecurity		usd
CY2021	zcmd	Acquisition Of A Subsidiary AcquisitionOfASubsidiary		usd
CY2020	zcmd	Acquisition Of A Subsidiary AcquisitionOfASubsidiary		usd
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2020	zcmd	Loans Repayment From Third Parties LoansRepaymentFromThirdParties		usd
CY2021	us-gaap	Increase Decrease In Lease Acquisition Costs IncreaseDecreaseInLeaseAcquisitionCosts		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	zcmd	Payment Of Expenses Relating To Initial Public Offerings PaymentOfExpensesRelatingToInitialPublicOfferings		usd
CY2021	zcmd	Payment Of Expenses Relating To Initial Public Offerings PaymentOfExpensesRelatingToInitialPublicOfferings		usd
CY2021	zcmd	Proceeds From Issuance Of Ordinary Shares In Connection With Direct Offering ProceedsFromIssuanceOfOrdinarySharesInConnectionWithDirectOffering		usd
CY2020	zcmd	Proceeds From Issuance Of Ordinary Shares In Connection With Direct Offering ProceedsFromIssuanceOfOrdinarySharesInConnectionWithDirectOffering		usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2020	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	zcmd	Sales Of Patented Drug SalesOfPatentedDrug		usd
CY2020	zcmd	Sales Of Patented Drug SalesOfPatentedDrug		usd
CY2020	zcmd	Other Consulting Services OtherConsultingServices		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables		usd
CY2021Q4	us-gaap	Inventory Net InventoryNet		usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill Noncurrent DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q4	zcmd	Due From Related Partie DueFromRelatedPartie		usd
CY2021	zcmd	Downward Adjustments In Investments In An Equity Security DownwardAdjustmentsInInvestmentsInAnEquitySecurity		usd
CY2021Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits		usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2021	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1		usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24425637	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24938513	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25997757	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.010
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.113
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.183
CY2021	zcmd	Beijing Ougaini BeijingOugaini		usd
CY2020	zcmd	Beijing Ougaini BeijingOugaini		usd
CY2021	zcmd	Beijings Ougaini BeijingsOugaini		usd
CY2021	zcmd	Yang Weiguangi YangWeiguangi		usd
CY2022	zcmd	Beijing Yisuizhenii BeijingYisuizhenii		usd
CY2021	zcmd	Sales Of Patented Drugs SalesOfPatentedDrugs		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001785566
CY2022	dei	Trading Symbol TradingSymbol	ZCMD

Files In Submission

Name	View Source	Status
0001213900-23-038650-index-headers.html	Edgar Link	pending
0001213900-23-038650-index.html	Edgar Link	pending
0001213900-23-038650.txt	Edgar Link	pending
0001213900-23-038650-xbrl.zip	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-1_003.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
f20f2022ex12-1_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex12-2_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex13-1_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex15-1_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex15-2_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex19-1_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex21-1_zhongchaoinc.htm	Edgar Link	pending
f20f2022ex4-3_zhongchaoinc.htm	Edgar Link	pending
f20f2022_zhongchao.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_001i.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f20f2022_zhongchao_htm.xml	Edgar Link	completed
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zcmd-20221231.xsd	Edgar Link	pending
zcmd-20221231_cal.xml	Edgar Link	unprocessable
zcmd-20221231_def.xml	Edgar Link	unprocessable
zcmd-20221231_lab.xml	Edgar Link	unprocessable
zcmd-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZCMD
Zhongchao Inc. Stock $zcmd

2022 Q4 Form 20-F Financial Statement

#000121390023038650 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZCMD Zhongchao Inc. Stock $zcmd

2022 Q4 Form 20-F Financial Statement

#000121390023038650 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZCMD
Zhongchao Inc. Stock $zcmd